Giovanni Galati1, Antonio De Vincentis2, Paolo Gallo3, Alessandro Guidi4, Umberto Vespasiani-Gentilucci5, Antonio Picardi6. 1. Hepatology and Clinical Medicine Unit of University Campus Bio-Medico of Rome. g.galati@unicampus.it. 2. Hepatology and Clinical Medicine Unit of University Campus Bio-Medico of Rome. a.devincentis@unicampus.it. 3. Hepatology and Clinical Medicine Unit of University Campus Bio-Medico of Rome. paolo.gallo@unicampus.it. 4. Hepatology and Clinical Medicine Unit of University Campus Bio-Medico of Rome. alessandroguidi91@gmail.com. 5. Hepatology and Clinical Medicine Unit of University Campus Bio-Medico of Rome. u.vespasiani@unicampus.it. 6. Hepatology and Clinical Medicine Unit of University Campus Bio Medico of Rome. a.picardi@unicampus.it.
Abstract
AIM: To evaluate the diagnostic value of Virtual Touch Quantification (VTQ®) for characterizing benign vs. malignant focal liver lesions (FLLs). MATERIAL AND METHODS: From January 2015 to January 2016 all consecutive FLLs visualized during a conventional abdominal ultrasound (US), underwent VTQ® evaluation, taking five measurements of both the lesion and the surrounding parenchyma. RESULTS: We studied 119 FLLs, consisting of 52 hemangiomas (HEs), 39 hepatocellular carcinomas (HCCs), and 28 liver metastases (METs). HEs showed a significantly lower shear wave velocity (SWV) values compared to malignant FLLs (HEs SWV median value 1.34 m/sec, IQR 0.9; malignant lesions SWV median value 2.69 m/sec, IQR 1.6; p<0.001). Moreover, a nodule-to-parenchyma SWV ratio showed a significant difference in HEs and METs (p<0.001) but not in HCCs (p=0.03). SWV values were able to correctly differentiate malignant lesions with c-statistics of 0.82 (95 % CI 0.74- 0.90) and sensitivity of 74.6%/specificity of 80.7% at a cut-off of 2 m/sec. CONCLUSIONS: Our results suggest that VTQ® is able to distinguish HEs from malignant lesions (HCCs and METs) at a SWV cut-off of 2 m/sec.
AIM: To evaluate the diagnostic value of Virtual Touch Quantification (VTQ®) for characterizing benign vs. malignant focal liver lesions (FLLs). MATERIAL AND METHODS: From January 2015 to January 2016 all consecutive FLLs visualized during a conventional abdominal ultrasound (US), underwent VTQ® evaluation, taking five measurements of both the lesion and the surrounding parenchyma. RESULTS: We studied 119 FLLs, consisting of 52 hemangiomas (HEs), 39 hepatocellular carcinomas (HCCs), and 28 liver metastases (METs). HEs showed a significantly lower shear wave velocity (SWV) values compared to malignant FLLs (HEs SWV median value 1.34 m/sec, IQR 0.9; malignant lesions SWV median value 2.69 m/sec, IQR 1.6; p<0.001). Moreover, a nodule-to-parenchyma SWV ratio showed a significant difference in HEs and METs (p<0.001) but not in HCCs (p=0.03). SWV values were able to correctly differentiate malignant lesions with c-statistics of 0.82 (95 % CI 0.74- 0.90) and sensitivity of 74.6%/specificity of 80.7% at a cut-off of 2 m/sec. CONCLUSIONS: Our results suggest that VTQ® is able to distinguish HEs from malignant lesions (HCCs and METs) at a SWV cut-off of 2 m/sec.